Office of the National Coordinator for Health Information Technology; HIT Policy Committee Meeting, 20950-20951 [E9-10643]

Download as PDF 20950 Federal Register / Vol. 74, No. 86 / Wednesday, May 6, 2009 / Notices Elizabeth Fertich, (703) 347–8560, fertich.elizabeth@epa.gov. 3. PP 9E7541. (EPA–HQ–OPP–2009– 0256). BASF Corporation, 100 Campus Dr., Florham Park, NJ 07932, proposes to establish an exemption from the requirement of a tolerance for residues of 2–Propenoic acid, 2–methyl-, polymers with Bu acrylate, Et acrylate, Me methacrylate and polyethylene glycol methacrylate C16-18-alkyl ethers (CAS No. 890051–63–5) under 40 CFR 180.960 when used as a pesticide inert ingredient as a surfactant in pesticide formulations without limitation. The petitioner believes no analytical method is needed because this petition is a request for an exemption from the requirement of a tolerance and no analytical method is required. Contact: Alganesh Debesai, (703) 308–8353, debesai.alganesh@epa.gov. List of Subjects Environmental protection, Agricultural commodities, Feed additives, Food additives, Pesticides and pests, Reporting and recordkeeping requirements. Dated: April 23, 2009. Daniel J. Rosenblatt, Acting Director, Registration Division, Office of Pesticide Programs. [FR Doc. E9–10503 Filed 5–5–09; 8:45 am] BILLING CODE 6560–50–S FEDERAL MARITIME COMMISSION mstockstill on PROD1PC66 with NOTICES Notice of Agreements Filed The Commission hereby gives notice of the filing of the following agreements under the Shipping Act of 1984. Interested parties may submit comments on agreements to the Secretary, Federal Maritime Commission, Washington, DC 20573, within ten days of the date this notice appears in the Federal Register. Copies of the agreements are available through the Commission’s Web site (https://www.fmc.gov) or contacting the Office of Agreements at (202) 523–5793 or tradeanalysis@fmc.gov. Agreement No.: 012044–002. Title: MOL/CMA CGM Slot Charter Agreement. Parties: CMA CGM S.A. and Mitsui O.S.K. Lines, Ltd. Filing Party: Robert B. Yoshitomi, Esq.; Nixon Peabody LLP; Gas Company Tower; 555 West Fifth Street, 46th Floor, Los Angeles, CA 90013. Synopsis: The amendment revises the number of slots MOL is authorized to sell to CMA CGM. Agreement No.: 201196–003. Title: Los Angeles and Long Beach Marine Terminal Agreement. VerDate Nov<24>2008 18:36 May 05, 2009 Jkt 217001 Parties: City of Los Angeles and City of Long Beach. Filing Party: Matthew J. Thomas, Esq.; Troutman Sanders LLP; 401 9th Street, NW., Suite 1000, Washington, DC 20004. Synopsis: The amendment revises the dates for collection and the amount of certain fees. By Order of the Federal Maritime Commission. Dated: May 1, 2009. Karen V. Gregory, Secretary. [FR Doc. E9–10501 Filed 5–5–09; 8:45 am] 1. FCB Florida Bancorporation, Inc., Orlando, Florida; to merge with Anderen Financial, Inc., and thereby acquire its subsidiary, Anderen Bank, both of Palm Harbor, Florida. Board of Governors of the Federal Reserve System, May 1, 2009. Robert deV. Frierson, Deputy Secretary of the Board. [FR Doc. E9–10435 Filed 5–5–09; 8:45 am] BILLING CODE 6210–01–S DEPARTMENT OF HEALTH AND HUMAN SERVICES BILLING CODE 6730–01–P FEDERAL RESERVE SYSTEM Formations of, Acquisitions by, and Mergers of Bank Holding Companies The companies listed in this notice have applied to the Board for approval, pursuant to the Bank Holding Company Act of 1956 (12 U.S.C. 1841 et seq.) (BHC Act), Regulation Y (12 CFR Part 225), and all other applicable statutes and regulations to become a bank holding company and/or to acquire the assets or the ownership of, control of, or the power to vote shares of a bank or bank holding company and all of the banks and nonbanking companies owned by the bank holding company, including the companies listed below. The applications listed below, as well as other related filings required by the Board, are available for immediate inspection at the Federal Reserve Bank indicated. The applications also will be available for inspection at the offices of the Board of Governors. Interested persons may express their views in writing on the standards enumerated in the BHC Act (12 U.S.C. 1842(c)). If the proposal also involves the acquisition of a nonbanking company, the review also includes whether the acquisition of the nonbanking company complies with the standards in section 4 of the BHC Act (12 U.S.C. 1843). Unless otherwise noted, nonbanking activities will be conducted throughout the United States. Additional information on all bank holding companies may be obtained from the National Information Center website at www.ffiec.gov/nic/. Unless otherwise noted, comments regarding each of these applications must be received at the Reserve Bank indicated or the offices of the Board of Governors not later than June 1, 2009. A. Federal Reserve Bank of Atlanta (Steve Foley, Vice President) 1000 Peachtree Street, N.E., Atlanta, Georgia 30309: PO 00000 Frm 00052 Fmt 4703 Sfmt 4703 Office of the National Coordinator for Health Information Technology; HIT Standards Committee Meeting ACTION: Announcement of meeting. SUMMARY: This notice announces the first meeting of the HIT Standards Committee in accordance with the Federal Advisory Committee Act (Pub. L. No. 92–463, 5 U.S.C., App.). DATES: May 15, 2009, from 9 a.m. to 12 p.m. [Eastern] ADDRESSES: Mary C. Switzer Building (330 C Street, SW., Washington, DC 20201), Conference Room 1114. Please use the C Street entrance closest to 3rd Street and bring photo ID for entry to a Federal building. FOR FURTHER INFORMATION CONTACT: https://healthit.hhs.gov SUPPLEMENTARY INFORMATION: This is the inaugural meeting of the HIT Standards Committee. Members will be introduced, and a schedule developed for the assessment of policy recommendations from the HIT Policy Committee. Space is limited, seating on a first-come, first-served basis. The meeting will be available via webcast. Because of initial delays in processing members’ nominations, the 15 day deadline for notification was not met. Judith Sparrow, Office of Programs and Coordination, Office of the National Coordinator for Health Information Technology. [FR Doc. E9–10642 Filed 5–4–09; 4:15 pm] BILLING CODE 4150–45–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Office of the National Coordinator for Health Information Technology; HIT Policy Committee Meeting ACTION: Announcement of meeting. SUMMARY: This notice announces the first meeting of the HIT Policy E:\FR\FM\06MYN1.SGM 06MYN1 Federal Register / Vol. 74, No. 86 / Wednesday, May 6, 2009 / Notices Committee in accordance with the Federal Advisory Committee Act (Pub. L. No. 92–463, 5 U.S.C., App.). DATES: May 11, 2009, from 8:30 a.m. to 11:30 a.m. [Eastern] ADDRESSES: Hubert H. Humphrey Building (200 Independence Avenue, SW., Washington, DC 20201), Conference Room 505A. Please bring photo ID for entry to a Federal building. FOR FURTHER INFORMATION CONTACT: https://healthit.hhs.gov. SUPPLEMENTARY INFORMATION: This is the inaugural meeting of the HIT Policy Committee. Members will be introduced. Space is limited, seating on a first-come, first-served basis. The meeting will be available via webcast. Because of initial delays in processing members’ nominations, the 15 day deadline for notification was not met. Judith Sparrow, Office of Programs and Coordination, Office of the National Coordinator for Health Information Technology. [FR Doc. E9–10643 Filed 5–4–09; 4:15 pm] BILLING CODE 4150–45–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Agency for Healthcare Research and Quality Agency Information Collection Activities: Proposed Collection; Comment Request mstockstill on PROD1PC66 with NOTICES AGENCY: Agency for Healthcare Research and Quality, HHS. ACTION: Notice. SUMMARY: This notice announces the intention of the Agency for Healthcare Research and Quality (AHRQ) to request that the Office of Management and Budget (OMB) approve the proposed information collection project: ‘‘Understanding Patients’ Knowledge and Use of Acetaminophen.’’ In accordance with the Paperwork Reduction Act of 1995, 44 U.S.C. 3506(c)(2)(A), AHRQ invites the public to comment on this proposed information collection. This proposed information collection was previously published in the Federal Register on February 26th, 2009 and allowed 60 days for public comment. One comment was received. The purpose of this notice is to allow an additional 30 days for public comment. DATES: Comments on this notice must be received by June 5, 2009. ADDRESSES: Written comments should be submitted to: AHRQ’s OMB Desk VerDate Nov<24>2008 18:36 May 05, 2009 Jkt 217001 Officer by fax at (202) 395–6974 (attention: AHRQ’s desk officer) or by email at OIRA_submission@omb.eop.gov (attention: AHRQ’s desk officer). Copies of the proposed collection plans, data collection instruments, and specific details on the estimated burden can be obtained from the AHRQ Reports Clearance Officer. FOR FURTHER INFORMATION CONTACT: Doris Lefkowitz, AHRQ Reports Clearance Officer, (301) 427–1477, or by e-mail at doris.lefkowitz@ahrq.hhs.gov. SUPPLEMENTARY INFORMATION: Proposed Project ‘‘Understanding Patients’ Knowledge and Use of Acetaminophen’’. This proposed data collection is a qualitative study to preliminarily identify issues that relate to the misuse and overdosing of over-the-counter (OTC) acetaminophen. Toxicity from acetaminophen has been on the rise in the past 3 decades, and is now the most common cause of acute liver failure in the U.S., surpassing viral hepatitis. This data collection has two aims. Aim 1 is to qualitatively explore knowledge, attitudes, beliefs, and practices regarding adult and adolescent selfadministration of OTC acetaminophen, and parental administration of OTC acetaminophen to children. To meet Aim 1 focus groups will be conducted with adults and semi-structured interviews will be conducted with adolescents. Aim 2 is to qualitatively explore experiences and practices of key professional informants, including physician and pharmacists, with respect to communicating information on the administration and risks of OTC acetaminophen to consumers and patients. Semi-structured interviews will be conducted with target key informants. The results of this qualitative study will provide an understanding of the relevant issues and will be used to develop a comprehensive survey. A second OMB clearance package will be developed once the questionnaire for the survey is available. This project is being funded by AHRQ pursuant to a cooperative agreement with the University of Pennsylvania (Award 1 U18HS017991) as part of the Centers for Education and Research on Therapeutics (CERTs) program. The CERTs program is a national initiative, administered by AHRQ in consultation with the Food and Drug Administration, to increase awareness of the benefits and risks of new, existing, or combined uses of therapeutics through education and research. See 42 U.S.C. 299b.–1(b). PO 00000 Frm 00053 Fmt 4703 Sfmt 4703 20951 Method of Collection Aim I—Focus Groups and Individual Interviews Four focus groups will be conducted with parents of young children to examine administration of acetaminophen to children. Four focus groups will also be conducted with adults to identify the issues, barriers, and psychosocial factors surrounding how, when, and why OTC acetaminophen is used. Focus groups will each have 6 to 8 participants. Semistructured interviews will be conducted with adolescents to examine selfadministration of acetaminophen among this group. Content areas to be explored are: a. knowledge about acetaminophen: brands, terms, combinations, dosage, administration, indications; b. beliefs about benefits and risks, including thresholds for toxicity and death; c. patterns and frequency of use; d. sources of information (e.g., physicians, pharmacists, media); e. related experiences in peers (e.g., advice, reports of toxicity); and f. views about labeling, packaging and legislation (e.g., restrictions in sales). Aim 2—Semi-Structured Interviews With Physicians and Pharmacists Twenty primary care physicians and 20 pharmacists will be interviewed. Primary care physicians will be recruited through a primary care research network of physicians from both private and public clinics. Pharmacists will be recruited at pharmacy facilities from hospitals and clinics. Interviews will be conducted over the phone or in person, according to the participant’s preference, and will last approximately 20 minutes. All interviews will be audio-taped and transcribed. Participants will be asked about the following: a. frequency and patterns of interaction with consumers and patients with respect to acetaminophen; b. types of information provided to consumers; c. availability of education materials; and d. views about labeling, packaging and legislation. Estimated Annual Respondent Burden Exhibit 1 shows the estimated annualized burden hours for the respondents’ time to participate in this project. The screening form will be completed by all participants and is expected to take approximately 3 minutes to complete. Focus groups will include populations: parents of children ´ o8 years of age and adults, and will last about 11⁄2 hours. Semi-structured interviews will be conducted with 20 adolescents, 20 primary care physicians, and 20 pharmacists and will last 20 to E:\FR\FM\06MYN1.SGM 06MYN1

Agencies

[Federal Register Volume 74, Number 86 (Wednesday, May 6, 2009)]
[Notices]
[Pages 20950-20951]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E9-10643]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES


Office of the National Coordinator for Health Information 
Technology; HIT Policy Committee Meeting

ACTION: Announcement of meeting.

-----------------------------------------------------------------------

SUMMARY: This notice announces the first meeting of the HIT Policy

[[Page 20951]]

Committee in accordance with the Federal Advisory Committee Act (Pub. 
L. No. 92-463, 5 U.S.C., App.).

DATES: May 11, 2009, from 8:30 a.m. to 11:30 a.m. [Eastern]

ADDRESSES: Hubert H. Humphrey Building (200 Independence Avenue, SW., 
Washington, DC 20201), Conference Room 505A. Please bring photo ID for 
entry to a Federal building.

FOR FURTHER INFORMATION CONTACT: https://healthit.hhs.gov.

SUPPLEMENTARY INFORMATION: This is the inaugural meeting of the HIT 
Policy Committee. Members will be introduced. Space is limited, seating 
on a first-come, first-served basis.
    The meeting will be available via webcast. Because of initial 
delays in processing members' nominations, the 15 day deadline for 
notification was not met.

Judith Sparrow,
Office of Programs and Coordination, Office of the National Coordinator 
for Health Information Technology.
[FR Doc. E9-10643 Filed 5-4-09; 4:15 pm]
BILLING CODE 4150-45-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.